Zai Lab Ltd (ZLAB) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.52 is considered Undervalued compared with the five-year average of -18.04. The fair price of Zai Lab Ltd (ZLAB) is between 58.31 to 65.96 according to relative valuation method. Compared to the current price of 17.72 USD , Zai Lab Ltd By Undervalued By 69.61%.

Relative Value

Fair Zone

58.31-65.96

Current Price：17.72

69.61%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Zai Lab Ltd (ZLAB) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Zai Lab Ltd (ZLAB) has a current Price-to-Book (P/B) ratio of 2.52. Compared to its 3-year average P/B ratio of 1.77, the current P/B ratio is approximately 42.42% higher. Relative to its 5-year average P/B ratio of 1.27, the current P/B ratio is about 98.59% higher. Zai Lab Ltd (ZLAB) has a Forward Free Cash Flow (FCF) yield of approximately -9.89%. Compared to its 3-year average FCF yield of -9.50%, the current FCF yield is approximately 4.11% lower. Relative to its 5-year average FCF yield of -9.30%, the current FCF yield is about 6.26% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ZLAB competitors is 34.79, providing a benchmark for relative valuation. Zai Lab Ltd Corp (ZLAB.O) exhibits a P/S ratio of 3.52, which is -89.88% above the industry average. Given its robust revenue growth of 16.99%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ZLAB increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ZLAB in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ZLAB currently overvalued or undervalued?

What is Zai Lab Ltd (ZLAB) fair value?

ZLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Zai Lab Ltd (ZLAB) is between 58.31 to 65.96 according to relative valuation method.

How does ZLAB's valuation metrics compare to the industry average?

The average P/S ratio for ZLAB's competitors is 34.79, providing a benchmark for relative valuation. Zai Lab Ltd Corp (ZLAB) exhibits a P/S ratio of 3.52, which is -89.88% above the industry average. Given its robust revenue growth of 16.99%, this premium appears unsustainable.

What is the current P/B ratio for Zai Lab Ltd (ZLAB) as of Mar 04 2026?

As of Mar 04 2026, Zai Lab Ltd (ZLAB) has a P/B ratio of 2.52. This indicates that the market values ZLAB at 2.52 times its book value.

What is the current FCF Yield for Zai Lab Ltd (ZLAB) as of Mar 04 2026?

As of Mar 04 2026, Zai Lab Ltd (ZLAB) has a FCF Yield of -9.89%. This means that for every dollar of Zai Lab Ltd's market capitalization, the company generates -9.89 cents in free cash flow.

What is the current Forward P/E ratio for Zai Lab Ltd (ZLAB) as of Mar 04 2026?

As of Mar 04 2026, Zai Lab Ltd (ZLAB) has a Forward P/E ratio of -18.08. This means the market is willing to pay $-18.08 for every dollar of Zai Lab Ltd's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Zai Lab Ltd (ZLAB) as of Mar 04 2026?

As of Mar 04 2026, Zai Lab Ltd (ZLAB) has a Forward P/S ratio of 3.52. This means the market is valuing ZLAB at $3.52 for every dollar of expected revenue over the next 12 months.

ZLAB Valuation